Cancer Caused by Byetta, Januvia, Janumet, or Victoza
You should not worry about getting cancer by taking your diabetic medication. Regrettably, recent research has discovered that Type 2 diabetes patients on Incretin Mimetics, such as Byetta, Janumet, Januvia, and Victoza are possibly 300% more likely to develop pancreatic cancer, an especially severe kind of cancer that is most typically identified when it’s too late to treat. If you think that you may have a claim for this type of matter, please contact us by filling out our online form or calling 713-654-4040 or 1-800-883-9858.
Pancreatitis is an inflammation of the pancreas, which is the organ that produces digesting enzymes. It also plays a role in blood sugar regulation by releasing the hormones insulin and glucagon. Pancreatitis develops when the digestive enzymes inside the pancreas become active (instead of the small intestine). The pancreas can be damaged by this disorder, which can be acute or evolve into a chronic illness. The following are symptoms of acute pancreatitis:
- Pain in the upper abdomen that may spread to the back
- Nausea
- Heart rate has increased.
- Abdomen swollen and painful
- Fever
- Vomiting
If you’ve been diagnosed with pancreatic cancer and have Type 2 diabetes, you should look over your medication history to see if you’ve used any of these medicines. If you or a loved one has experienced pancreatic cancer after taking one of these medications, our dangerous drug lawyers are ready to fight for you. Call us at 713-654-4040 or 1-800-883-9858 to talk about your potential claim.
Who Made These Dangerous Diabetic Drugs?
- Byetta (Exenatide) is an injectable medication that was introduced to the market in 2005 by Amylin Pharmaceuticals in collaboration with Eli Lilly and Co.
- Merck & Co. developed and manufactured Januvia/Janumet(Sitagliptin), an oral medication that was introduced to the market in 2006.
- Victoza (Liraglutide), a Novo Nordisk-developed and-manufactured injectable therapy, was introduced to the market in 2010.
Pancreatic Cancer and Incretin Mimetics
The use of Byetta or Januvia by individuals with Type 2 diabetes was related to considerably higher probabilities of acute pancreatitis, according to research published in the Journal of the American Medical Association (JAMA) in April 2013. Pancreatic cancer can develop as a result of chronic pancreatitis.
The FDA issued a safety statement following the release of this report, warning of a possible elevated risk of pancreatitis and pre-cancerous findings of the pancreas with incretin mimetic medicines for Type 2 diabetes.
Also, a 2011 research published in the science magazine Gastroenterology found that diabetics on Byetta or Januvia are 600% more likely than those taking other medicines to develop pancreatitis. Diabetics on Byetta or Januvia were 2.9 times and 2.7 times more likely than those taking other diabetes treatments to develop pancreatic cancer.
Attorneys for Dangerous Drugs
For nearly 40 years, the Willis Law Firm has been at the forefront of researching and obtaining justice for clients who have been hurt by faulty medications like these. David P. Willis is board certified as a personal injury trial law specialist. We know your rights, what’s on the line, and how to handle drug claims from start to finish. Our Houston law firm helps patients and families across the United States find justice for their injuries caused by dangerous drugs. We achieve remarkable results. Please contact us by filling out our online form or calling 713-654-4040 or 1-800-883-9858.